• Produktbild: Immunology of Silicones
  • Produktbild: Immunology of Silicones
Band 210

Immunology of Silicones

97,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Lieferung nach Hause

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

09.02.2012

Herausgeber

Michael Potter + weitere

Verlag

Springer Berlin

Seitenzahl

430

Maße (L/B/H)

23,5/15,5/2,5 cm

Gewicht

686 g

Auflage

Softcover reprint of the original 1st ed. 1996

Sprache

Englisch

ISBN

978-3-642-85228-2

Beschreibung

Portrait

Michael Potter is Reader in the Philosophy of Mathematics at Cambridge University. He is the author of Sets (OUP, 1990), Reason's Nearest Kin (OUP, 2000), Set Theory and its Philosophy (OUP, 2004), and Mathematical Knowledge (edited with Mary Leng and Alexander Paseau, OUP, 2007).

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

09.02.2012

Herausgeber

Verlag

Springer Berlin

Seitenzahl

430

Maße (L/B/H)

23,5/15,5/2,5 cm

Gewicht

686 g

Auflage

Softcover reprint of the original 1st ed. 1996

Sprache

Englisch

ISBN

978-3-642-85228-2

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

  • Produktbild: Immunology of Silicones
  • Produktbild: Immunology of Silicones
  • Silicon, Silica, Silicones: Chemistry and Degradation.- Silica, Silicon and Silicones … Unraveling the Mystery.- Silicone Degradation Reactions.- Chemical, Physical and Mechanical Analysis of Explanted Breast Implants.- Silicon and Silicone Levels in Patients with Silicone Implants.- Detection of Silicone Migration and Biodegration with NMR.- Serum Silicon Levels are Elevated in Women with Silicone Gel Implants.- Interaction of Silicones with Proteins and Tissues.- The Development of an ELISA Method for the Detection of “Antibodies” to Silicone.- The Adsorption of Proteins on a Polydimethylsiloxane Elastomer (PEP) and Their Antigenic Behavior.- Aspecific Immunoglobin Binding to Hydrophobic Surfaces.- Cytotoxicity and Membrane Damage in vitro by Inclusion Complexes Between ?-cyclodextrin and Siloxanes.- Adjuvancy of Silicones.- Induction of Type-Il Collagen Arthritis in the DA Rat Using Silicone Gel as Adjuvant.- The Adjuvancy of Silicones: Dependency on Compartmentalization.- The Adjuvant Effect of Silicone Gel and Silicone Elastomer Particles in Rats.- Silicone Gel and Octamethylcyclotetrasiloxane Potentiate Antibody Production to Bovine Serum Albumin in Mice.- Macrophages, Polyreactive and Antilipid Antibodies.- Fibrogenic and Other Biological Effects of, Silica.- Macrophages in Host Defense Mechanisms.- Structure and Function of, Natural Antibodies.- Antibodies to, Cholesterol: Biological Implications of Antibodies to Lipids.- T-Cell, NK Cell Responses to Silicones.- Silicone-lnduced, T-cell Proliferation in Mice.- Silicone-induced, Modulation of Natural Killer Cell Activity.- HLA Typing in Women with and, without Silicone Gel-filled Breast Implants.- T Cell-Mediated Immune Response to Silica in Silicone Breast Implant Patients.- Immunohistopathology and T-cell Receptor Gene Expression in Capsules Surrounding Silicone Breast Implants.- Cellular Reactions to Silicone Implants.- Macrophage-Silicone Interactions in Women with Breast Prostheses.- Microscopic Techniques and Histologic Finding in Silicone Mammary Implant Capsules and Regional Paranodal Tissues.- Autoimmune Antibodies.- Antinuclear Antibodies in Apparently Healthy Women with Breast Implants.- Silicone Binding Immunoglobulins in Human Sera. With 6 Figures.- Autoantibodies in Patients with Silicone Implants.- Clinical and Laboratory Features of Patients with Scleroderma and Silicone Implants.- Re-Evaluation of Autoantibodies and Clinical Overview of Silicone-Related Disorders. With 1 Figure.- Development of Scleroderma-like Syndrome in Tsk/+ Mice is not Enhanced by Silicone Administration.- Comparative Epitope Mapping of Antibodies to Collagen in Women with Silicone Breast Implants, Systemic Lupus Erythematosus and Rheumatoid Arthritis.- The Prevalence of Autoantibodies in Symptomatic and Asymptomatic Patients with Breast Implants and Patients with Fibromyalgia.- Monocyte/Macrophage Infiltrates in the Salivary Glands of Women with Silicone Breast Implants.- Novel Anti-Silicone Surface-associated Antigen Antibodies (anti-SSAA(x)) may help Differentiate Symptomatic Patients with Silicone Breast Implants from Patients with Classical Rheumatological Disease.- Laboratory Studies in Breast Implant Patients: ANA Positivity Gammaglobulin Levels, and Other Autoantibodies.- MGUS, Myeloma, Plasmacytoma.- IS the Risk of Multiple Myeloma Increased in Patients with Silicone Implants?.- Multiple Myeloma in Women with Silicone Breast Implants. Serum Immunoglobulin and lnterleukin-6 Studies in Women at Risk. With 3 Figures.- Silicone Gel Implants and Monoclonal Gammopathies: Three Cases of Multiple Myeloma and the Prevalence of Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance.- Monoclonal Gammopathy of Undetermined Significance.- The National Cancer Institute Silicone Implant/Multiple Myeloma Registry.- The Epidemiology of Monoclonal Gammopathy of Unknown Significance: A Review.- Plasmacytoma Development in Mice Injected with Silicone Gels. With 6 Figures.- Epidemiology.- The Association of Augmentation Mammoplasty with Connective Tissue Disease, Including Systematic Sclerosis (Scleroderma): A Meta-Analysis.- The Prevalence of Breast Implants Among Women in the United States.- Epidemiology of Autoimmune and Immunological Diseases in Association with Silicone Implants: Is There an Excess of Clinical Disease or Antibody Response in Population-based or Other “Controlled” Studies?.